Receiving approval and enabling patient access are not the same challenge in the US. Coverage, patient cost, channel structure and contract economics shape commercial access together.
Map the access stakeholders
Depending on the product, Medicare, Medicaid, commercial insurers, PBMs, health systems, pharmacies and other channels may play different roles. Their decision criteria and evidence needs are not identical.
Look beyond list price
Pricing should consider gross-to-net assumptions, discounts, contracting, distribution economics and patient-support needs. Current public-program rules should always be confirmed through official CMS resources.
- Map the target patient journey and payment flow.
- Document coverage and evidence assumptions.
- Evaluate channel economics through scenarios.
- Refresh pricing decisions as the environment changes.
Test access assumptions before launch
When access assumptions are tested late, forecasts and operating plans may become unrealistic. Evaluate how alternative coverage, price and channel scenarios affect volume, cash flow and capability requirements before launch.
Kaynaklar / Sources
This article is for general information and is not legal, regulatory or medical advice. Confirm product-specific requirements with qualified specialists and the relevant authorities.
